Your account is not claimed yet. You can sign up with ORCID to claim your account.

Cheol-Kyu Park (Cheol Kyu Park)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 19

Top Venues

Thoracic cancer

Journal of Korean medical science

Cells

Cancers

Chonnam National University Hwasun Hospital

Chonnam National University Medical School (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chonnam National University Hwasun Hospital

South Korea

Assistant Professor :: Pulmonology

Education History

Chonnam National University Medical School Mar 1o 2010 - Aug 31o 2017

South Korea

PHD

Publications

Cheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park, Hyung-Joo Oh, Young-Chul Kim, Ha Lim Jeon, Yong-Hyub Kim, Sung-Ja Ahn, In Jae Oh
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
In Jae Oh, Cheol-Kyu Park, Kyoung-Bok Min, Jin-Young Min, Chaeuk Chung, Seong Hoon Yoon, Chang-Soo Kim, Sei-Hoon Yang
Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study. Thoracic cancer (2023)
Cheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park, Hyung-Joo Oh, Young-Chul Kim, Ha Lim Jeon, Yong-Hyub Kim, Sung-Ja Ahn, In Jae Oh
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Hayoung Choi, Jae-Kyeong Lee, Hyung-Joo Oh, Min-Seok Kim, Bo Gun Kho, Cheol-Kyu Park, In Jae Oh, Young-Chul Kim
Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatment. Thoracic cancer 12 (10) (2021)
Cheol-Kyu Park, Sung-Yong Lee, Jae Cheol Lee, Chang-Min Choi, Shin Yup Lee, Tae-Won Jang, In Jae Oh, Young-Chul Kim
Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A. Thoracic cancer 12 (4) (2020)
Da Hyun Kang, Cheol-Kyu Park, Chaeuk Chung, In Jae Oh, Young-Chul Kim, Dong Il Park, Jinhyun Kim, Gye Cheol Kwon, In Sun Kwon, Pureum Sun, Eui-Cheol Shin, Jeong Eun Lee
Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors. Immune network 20 (3) (2020)
Hyung-Joo Oh, Won Gi Jeong, Yongwhan Lim, Sang-Joon Koh, Sung Min Lee, Min-Seok Kim, Bo-Gun Koh, Tae-Ok Kim, Yoo-Duk Choi, In Jae Oh, Young-Chul Kim, Cheol-Kyu Park
Potentially fatal complications of systemic air embolism after computed tomography-guided transthoracic needle biopsy in lung cancer harboring epithelial growth factor receptor mutation: A case report. Thoracic cancer 11 (11) (2020)
Bo Gun Kho, Ha-Young Park, Hyun-Joo Cho, Cheol-Kyu Park, Young-Chul Kim, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Yoo-Duk Choi, Seung-Won Lee, In Jae Oh
Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery. Journal of clinical medicine 9 (12) (2020)
Joon-Young Yoon, Cheol-Kyu Park, Yoo-Duk Choi, In Jae Oh, Young-Chul Kim
Predictive factors for long-term responders of pemetrexed maintenance treatment in non-small cell lung cancer. Thoracic cancer 10 (4) (2019)
In Jae Oh, Cheol-Kyu Park, Young-Chul Kim
Superior vena cava syndrome with extensive collateral vessels. Thoracic cancer 10 (12) (2019)
Young Ju Jung, In Jae Oh, Youndong Kim, Jong Ha Jung, Minkyoung Seok, Woochang Lee, Cheol-Kyu Park, Jung-Hwan Lim, Young-Chul Kim, Woo Sung Kim, Chang-Min Choi
Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer. Journal of Korean medical science 33 (53) (2018)
Cheol-Kyu Park, Jae Young Hur, Chang-Min Choi, Tae Ok Kim, Hyun Ju Cho, Hong Joon Shin, Jung-Hwan Lim, Yoo Duk Choi, Young-Chul Kim, In Jae Oh
Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report. Journal of Korean medical science 33 (1) (2018)
Cheol-Kyu Park, In Jae Oh, Young Chul Kim
What is Currently the Best for Adenocarcinoma without Driver Mutation? Tuberculosis and respiratory diseases 81 (3) (2018)
Cheol-Kyu Park, Hyun Wook Kang, In Jae Oh, Young-Chul Kim, Yeo Kyeoung Kim, Kook Joo Na, Sung Ja Ahn, Tae Ok Kim, Young Jin Choi, Geun Am Song, Min Ki Lee
Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study. Journal of Korean medical science 31 (12) (2017)
Cheol-Kyu Park, Hong Joon Shin, Yu-Il Kim, Sung-Chul Lim, Jeong-Sun Yoon, Young-Su Kim, Jung Chul Kim, Yong Soo Kwon
Predictors of Default from Treatment for Tuberculosis: a Single Center Case-Control Study in Korea. Journal of Korean medical science 31 (2) (2016)

Cheol-Kyu Park.css-eqlu8i{font-size:small;padding-left:4px;} (Cheol Kyu Park)

Publication Activity (10 Years)

Top Topics

Top Venues

Cheol-Kyu Park (Cheol Kyu Park)